Institut Du Cancer De Montpellier - Val D'aurelle

This study tested whether adding a targeted antibody drug (cetuximab) to a standard chemotherapy combination works better as the first treatment for colorectal cancer that has spread. It involved 42 patients with metastatic colorectal cancer who hadn't received prior treatment fo…

This study tested a combination of two treatments—a drug called regorafenib and a modified chemotherapy regimen (mGEMOX)—for people with advanced bile duct cancer that could not be cured by surgery. The main goals were to find a safe dose of the drug combination and to see how we…

This study tested whether using more intensive chemotherapy combinations could help people with colorectal cancer that had spread to the liver and could not be easily removed by surgery. It compared a standard two-drug treatment against three different, stronger chemotherapy opti…

This study tested the safety and effectiveness of combining two cancer drug regimens—regorafenib and FOLFIRINOX—for patients with advanced colorectal cancer that has spread and has a specific RAS gene mutation. The main goal was to find the highest dose patients could tolerate wi…

This study tested whether giving breast cancer patients a personalized dose of vitamin D, based on their individual deficiency level, works better than a standard one-size-fits-all dose to correct the deficiency. It involved 215 patients who had recently finished chemotherapy. Th…

This study tested whether adding the drug sorafenib to standard chemotherapy (irinotecan) could help control advanced colorectal cancer that had stopped responding to prior treatments. It involved 64 patients whose cancer had a specific genetic change (K-RAS mutation) and had spr…

This study tested whether combining three existing drugs could better control advanced pancreatic cancer that had spread. Sixty-three patients received gemcitabine by IV, trastuzumab by IV, and erlotinib as a daily pill. Researchers measured how well the combination stopped or sl…

This study tested whether adding the drug sorafenib to irinotecan chemotherapy works better than either drug alone for people with advanced colorectal cancer that has a specific genetic change (KRAS mutation) and has stopped responding to all standard treatments. It involved 173 …

This study tested whether a simple blood test could predict which breast and prostate cancer patients would develop severe long-term side effects from radiation therapy. Researchers measured how certain immune cells reacted to radiation in the lab. The goal was to identify the 5%…

This study tested whether a yoga program could help breast cancer patients manage joint pain caused by hormone therapy. Researchers taught 24 patients yoga poses to practice at home, aiming to see if this was a practical approach. They measured whether patients stuck with the pro…

This study tested whether using e-health tools could help patients better manage pain and anxiety after a breast biopsy. Researchers compared standard follow-up care to two new approaches: regular phone check-ins with a professional or using a smartphone/tablet app to report symp…

This study tested if a guided breathing technique called 'cardiac coherence,' paired with a hypnosis session, could help reduce anxiety before surgery and improve recovery afterward. It involved 53 adults scheduled for breast or gynecologic cancer surgery. The goal was to see if …

This study aimed to understand the type of memory problems people with cancer experience, specifically whether they struggle more with remembering past events or remembering to do future tasks. Researchers compared 426 people, including those with brain tumors, breast cancer, and…

This study aimed to understand how standard chemotherapy for breast cancer affects the body's calcium and vitamin D levels. Researchers followed 146 patients through their treatment to see if they developed high calcium in their urine, a potential side effect. The goal was to gat…

This study aimed to find better ways to detect when breast cancer spreads to the lining of the brain and spinal cord, a serious complication with poor survival. Researchers collected spinal fluid from 51 patients with suspected spread to test new biological markers. The goal was …

This study aimed to understand how a chemotherapy drug called temozolomide (TMZ) affects the thinking skills and quality of life of adults with a specific slow-growing brain tumor (diffuse low-grade glioma). Researchers followed 26 patients over a year to measure changes in memor…

This study aimed to find biological markers in blood and tumor tissue that could help predict how patients with esophageal or rectal cancer will respond to treatment before they start it. Researchers collected samples from 160 patients who were scheduled to receive chemotherapy a…